Anixa Biosciences Inc (ANIX)
3.00
+0.13
(+4.53%)
USD |
NASDAQ |
May 10, 16:00
3.005
0.00 (0.00%)
After-Hours: 20:00
Anixa Biosciences Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2023 | -1.09K% |
| January 31, 2023 | |
| October 31, 2022 | |
| July 31, 2022 | |
| April 30, 2022 | |
| January 31, 2022 | |
| October 31, 2021 | |
| July 31, 2021 | |
| April 30, 2021 | |
| January 31, 2021 | -430.4% |
| October 31, 2020 | |
| July 31, 2020 | |
| April 30, 2020 | |
| January 31, 2020 | |
| October 31, 2019 | |
| July 31, 2019 | |
| April 30, 2019 | -1.02K% |
| January 31, 2019 | |
| October 31, 2018 | |
| July 31, 2018 | -1.51K% |
| April 30, 2018 | -183.8% |
| January 31, 2018 | |
| October 31, 2017 | |
| July 31, 2017 | -495.0% |
| April 30, 2017 |
| Date | Value |
|---|---|
| January 31, 2017 | |
| October 31, 2016 | -523.8% |
| July 31, 2016 | -1.10K% |
| April 30, 2016 | |
| January 31, 2016 | |
| October 31, 2015 | |
| July 31, 2015 | -1.69K% |
| April 30, 2015 | -8.95K% |
| January 31, 2015 | 41.08% |
| October 31, 2014 | -229.3% |
| July 31, 2014 | 34.62% |
| April 30, 2014 | -294.1% |
| January 31, 2014 | |
| October 31, 2013 | -752.7% |
| July 31, 2013 | |
| April 30, 2013 | |
| January 31, 2013 | |
| October 31, 2012 | |
| July 31, 2012 | -252.2% |
| April 30, 2012 | -353.6% |
| January 31, 2012 | -197.3% |
| October 31, 2011 | -621.7% |
| July 31, 2011 | -393.8% |
| April 30, 2011 | -1.48K% |
| January 31, 2011 | -9.00K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.09K%
Minimum
Apr 2023
-430.4%
Maximum
Jan 2021
-760.0%
Average
-760.0%
Median
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -19.35K% |
| IGC Pharma Inc | -2.74K% |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Protalix BioTherapeutics Inc | -57.64% |